Company announcement – No. 16 / 2020
Zealand Pharma’s Annual General Meeting 2020
At the meeting, all proposals presented to the General Meeting were adopted.
The General Meeting acknowledged the management's report on Zealand's activities in the past financial year and Zealand's audited Annual Report for 2019 was approved. The meeting also approved that the financial result for 2019, i.e. a loss of
All the incumbent board members were re-elected as recommended by the Nomination Committee. Hence, Zealand's Board of Directors consists of the following members:
Alf Gunnar Martin Nicklasson Kirsten Aarup Drejer Alain Munoz Jeffrey Berkowitz Michael John Owen Leonard Kruimer Bernadette Mary Connaughton
After the Annual General Meeting, the Board of Directors constituted itself with
In addition, an employee election had been conducted prior to the Annual General Meeting and the following employee representatives had thus been elected to the board of directors on a 4-year term:
- Jens Peter Stenvang (employee elected)
- Gertrud K. Rasmussen (employee elected)
- Frederik B. Beck (employee elected)
- Louise Gjelstrup (employee elected)
ERNST & YOUNG Godkendt Revisionspartnerselskab was elected as Zealand's new auditor, replacing
The Board of Directors was authorized to allow Zealand to acquire, in the period until the next Annual General Meeting, treasury shares directly and/or acquire American Depositary shares for a nominal value of up to 10% of Zealand's share capital from time to time.
Zealand's new Remuneration Policy subject to the new regulation from the implementation of the Shareholders Rights Directive (Directive (EU) 2017/828 of
The fees for the Board of Directors for the financial year 2020 were approved by the General Meeting.
The Board of Directors was authorized to increase the share capital of Zealand during the period until
Finally, the General Meeting approved a new authorization to the Board of Directors to issue warrants during the period until
The Board of Directors
For further information, please contact:
Zealand Pharma Investor Relations
+45 50 60 38 00 investors@zealandpharma.com
lpm@zealandpharma.com
About
Zealand is based in
Attachment
- 16-20_0403_ZealandPharma AGM 2020
© OMX, source